跳至主要内容
临床试验/IRCT20161123031040N4
IRCT20161123031040N4已完成2 期

Comparison of the response rate and adverse effect between two groups of adjuvant short course high dose rate intravaginal brachytherapy vs conventional brachytherapy in primary endometrial cancer

Tehran University of Medical Sciences0 个研究点目标入组 104 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
104

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
Female

入选标准

  • Patients who suffer from endometrial adenocarcinoma stage 1 or 2
  • Patient's age will be between 18 to 75 years
  • Patients who have underwent total abdominal hysterectomy and bilateral sapping-oophorectomy
  • Karnofski Performance Status should be more than 70

排除标准

  • Patient receive other adjuvant therapies like chemotherapy.
  • Histological pathology of papillary serous carcinoma or clear cell carcinoma
  • Presence of commodities like severe hypertension or myocardial infarction
  • Patient refuses the treatment

研究者

相似试验